A nomogram using cytogenetics, TP53, and NPM1 mutational status can predict responses to induction chemotherapy in AML.
Konstantinos LontosAnastasia TsagianniMounzer AghaAnastasios RaptisJing-Zhou HouRafic FarahRobert L RednerAnnie ImKathleen A DorritieAlison SehgalJames RossettiNidhi AggarwalMelissa SaulWilliam GoodingMichael BoyiadzisPublished in: Leukemia & lymphoma (2022)